The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suri, A.
Right arrow Articles by Unanue, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suri, A.
Right arrow Articles by Unanue, E. R.
The Journal of Immunology, 2002, 168: 1235-1243.
Copyright © 2002 by The American Association of Immunologists

In APCs, the Autologous Peptides Selected by the Diabetogenic I-Ag7 Molecule Are Unique and Determined by the Amino Acid Changes in the P9 Pocket1

Anish Suri*, Ilan Vidavsky{dagger}, Koen van der Drift{dagger}, Osami Kanagawa*, Michael L. Gross{dagger} and Emil R. Unanue2,*

* Department of Pathology and Immunology, and Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110; and {dagger} Department of Chemistry, Washington University, St. Louis, MO 63130

We demonstrate in this study the great degree of specificity in peptides selected by a class II MHC molecule during processing. In this specific case of the diabetogenic I-Ag7 molecule, the P9 pocket of I-Ag7 plays a critical role in determining the final outcome of epitope selection, a conclusion that is important in interpreting the role of this molecule in autoimmunity. Specifically, we examined the display of naturally processed peptides from APCs expressing either I-Ag7 molecules or a mutant I-Ag7 molecule in which the {beta}57Ser residue was changed to an Asp residue. Using mass spectrometry analysis, we identified over 50 naturally processed peptides selected by I-Ag7-expressing APCs. Many peptides were selected as families with a core sequence and variable flanks. Peptides selected by I-Ag7 were unusually rich in the presence of acidic residues toward their C termini. Many peptides contained short sequences of two to three acidic residues. In binding analysis, we determined the core sequences of many peptides and the interaction of the acidic residues with the P9 pocket. However, different sets of peptides were isolated from APCs bearing a modified I-Ag7 molecule. These peptides did not favor acidic residues toward the carboxyl terminus.




This article has been cited by other articles:


Home page
Int ImmunolHome page
K. Y. Chang and E. R. Unanue
Prediction of HLA-DQ8 {beta} cell peptidome using a computational program and its relationship to autoreactive T cells
Int. Immunol., June 1, 2009; 21(6): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. G. Levisetti, D. M. Lewis, A. Suri, and E. R. Unanue
Weak Proinsulin Peptide-Major Histocompatibility Complexes Are Targeted in Autoimmune Diabetes in Mice
Diabetes, July 1, 2008; 57(7): 1852 - 1860.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Suri, J. J. Walters, H. W. Rohrs, M. L. Gross, and E. R. Unanue
First Signature of Islet {beta}-Cell-Derived Naturally Processed Peptides Selected by Diabetogenic Class II MHC Molecules
J. Immunol., March 15, 2008; 180(6): 3849 - 3856.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. G. Levisetti, A. Suri, S. J. Petzold, and E. R. Unanue
The Insulin-Specific T Cells of Nonobese Diabetic Mice Recognize a Weak MHC-Binding Segment in More Than One Form
J. Immunol., May 15, 2007; 178(10): 6051 - 6057.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. L. Donermeyer, K. S. Weber, D. M. Kranz, and P. M. Allen
The Study of High-Affinity TCRs Reveals Duality in T Cell Recognition of Antigen: Specificity and Degeneracy
J. Immunol., November 15, 2006; 177(10): 6911 - 6919.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. F. Shih, J. Racz, and P. M. Allen
Differential MHC Class II Presentation of a Pathogenic Autoantigen during Health and Disease
J. Immunol., March 15, 2006; 176(6): 3438 - 3448.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. J. Felix, A. Suri, J. J. Walters, S. Horvath, M. L. Gross, and P. M. Allen
I-Ep-Bound Self-Peptides: Identification, Characterization, and Role in Alloreactivity
J. Immunol., January 15, 2006; 176(2): 1062 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. G. Levisetti, A. Suri, I. Vidavsky, M. L. Gross, O. Kanagawa, and E. R. Unanue
Autoantibodies and CD4 T cells target a {beta} cell retroviral envelope protein in non-obese diabetic mice
Int. Immunol., December 1, 2003; 15(12): 1473 - 1483.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Suri, J. J. Walters, O. Kanagawa, M. L. Gross, and E. R. Unanue
Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition
PNAS, April 29, 2003; 100(9): 5330 - 5335.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
S. E. Starwalt, E. L. Masteller, J. A. Bluestone, and D. M. Kranz
Directed evolution of a single-chain class II MHC product by yeast display
Protein Eng. Des. Sel., February 1, 2003; 16(2): 147 - 156.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Velazquez, I. Vidavsky, K. van der Drift, M. L. Gross, and E. R. Unanue
Chemical Identification of a Low Abundance Lysozyme Peptide Family Bound to I-Ak Histocompatibility Molecules
J. Biol. Chem., November 1, 2002; 277(45): 42514 - 42522.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.